Adhera Therapeutics, Inc. (21) | Business Finance (15)
Browse by Subcategory
Recent Contracts
-
Form of Warrant
(Filed With SEC on April 23, 2021)
-
Form of Convertible Promissory Note
(Filed With SEC on April 23, 2021)
-
Security Agreement dated June 26, 2020
(Filed With SEC on June 30, 2020)
-
Securities Purchase Agreement dated as of February 5, 2020 between Adhera Therapeutics, Inc. and the purchasers identified on the signature pages thereto
(Filed With SEC on February 11, 2020)
-
Form of Subscription Agreement
(Filed With SEC on August 7, 2019)
-
Form of Subscription Agreement used in connection with the offering of the Series F Convertible Preferred Stock of the Registrant
(Filed With SEC on April 16, 2019)
-
Form of Warrant
(Filed With SEC on February 9, 2021)
-
Form of Convertible Promissory Note
(Filed With SEC on February 9, 2021)
-
Form of Warrant
(Filed With SEC on November 5, 2020)
-
Form of Senior Secured Convertible Note
(Filed With SEC on November 5, 2020)
-
Form of Convertible Promissory Note
(Filed With SEC on June 30, 2020)
-
Form of Convertible Promissory Note
(Filed With SEC on February 11, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on February 11, 2020)
-
Form of Secured Promissory Note
(Filed With SEC on July 3, 2019)
-
Security Agreement, dated as of June 28, 2019, among Adhera Therapeutics, Inc., IThenaPharma, Inc., Cequent Pharmaceuticals, Inc., MDRNA Research, Inc., the purchasers of secured...
(Filed With SEC on July 3, 2019)
